Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer (Q36618871)
Jump to navigation
Jump to search
scientific article published on 24 November 2015
Language | Label | Description | Also known as |
---|---|---|---|
English | Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer |
scientific article published on 24 November 2015 |
Statements
1 reference
Potent efficacy of metronomic topotecan and pazopanib combination therapy in preclinical models of primary or late stage metastatic triple-negative breast cancer (English)
1 reference
Ping Xu
Shan Man
Guido Bocci
24 November 2015
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference